Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

11 results
Display

Surgical management of the knee in rheumatoid arthritis

Lee MC, Han I

  • KMID: 2168066
  • Hanyang Med Rev.
  • 2005 May;25(2):89-93.
No Abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cytokines in rheumatoid arthritis

Ji JD

  • KMID: 2168061
  • Hanyang Med Rev.
  • 2005 May;25(2):43-52.
Rheumatoid arthritis is a common, chronic inflammatory arthritis that affects mainly the small diarthrodial joints of hands and feet. Although the cause of this disease remains unknown, the extensive researches...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
B cells and autoantibody in RA pathogenesis

Lee J

  • KMID: 2168058
  • Hanyang Med Rev.
  • 2005 May;25(2):21-25.
Rheumatoid arthritis (RA) is a chronic symmetric polyarthritis with autoimmune pathogenesis and is a cause of major disability. Although multiple theories involving B cells and autoantibody, T cell-mediated antigen specific...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Genentics in Rheumatoid Arthritis

Lee HS

  • KMID: 2168057
  • Hanyang Med Rev.
  • 2005 May;25(2):13-20.
The understanding of genetic factors contributed to the susceptibility or severity of rheumatoid arthritis (RA) might give new insights into the pathways involved in disease pathogenesis and lead to the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epidemiology and Diagnosis of Rheumatoid Arthritis

Lee JH, Kim SI

  • KMID: 2168056
  • Hanyang Med Rev.
  • 2005 May;25(2):4-12.
Rheumatoid arthritis (RA) is the most common chronic inflammatory joint disease. The prevalence of RA is between 0.5~1% and annual incidence of RA is approximately 0.2~0.4/1,000 persons. The prevalence and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Disease Modifying Antirheumatic Drugs in Rheumatoid Artritis

Suh CH

  • KMID: 2168064
  • Hanyang Med Rev.
  • 2005 May;25(2):73-79.
Rheumatoid arthritis (RA) is a chronic progressive disease, affecting an estimated 1% of the population worldwide. Although the optimal care of RA patients requires various modalities, pharmacotherapy remains the cornerstone...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lessons for the pathogenesis of rheumatoid arthritis acquired from experimental animal models

Youn J

  • KMID: 2168062
  • Hanyang Med Rev.
  • 2005 May;25(2):53-66.
Rheumatoid arthritis, a common human disease with a prevalence of about 1%, is characterized by inflammatory autoimmune responses. However, the etiopathogenesis of rheumatoid arthritis is still incompletely understood. A variety...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Role of T lymphocyte in the pathogenesis of rheumatoid arthritis

Shim SC, Lim MK, Sheen DH

  • KMID: 2168059
  • Hanyang Med Rev.
  • 2005 May;25(2):26-35.
PURPOSE OF REVIEW: Rheumatoid arthritis (RA) is characterized by a chronic T-cell response that has escaped normal control mechanisms. This review summarizes recent insights in pathways that are functional in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Biologic Therapy in Rheumatoid Arthritis

Koh EM

  • KMID: 2168065
  • Hanyang Med Rev.
  • 2005 May;25(2):80-88.
Rheumatoid arthritis (RA) is a common autoimmune disease of unknown etiology characterized by symmetric and erosive synovitis. The course of RA is usually chronic and progressive, so it can result...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Role of Synovial Fibroblasts in Rheumatoid Arthritis

Lee SH

  • KMID: 2168060
  • Hanyang Med Rev.
  • 2005 May;25(2):36-42.
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovial tissue proliferation with progressive joint destruction. The etiology of RA remains unknown, but many factors, including autoimmunity, cytokines and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cyclooxygenase-2 Inhibitors and Cardivascular Risk

Park YB

  • KMID: 2168063
  • Hanyang Med Rev.
  • 2005 May;25(2):67-72.
Serious concerns about the cardiovascular safety of rofecoxib had been present since the VIOXX(R) Gastrointestinal Outcomes Research (VIGOR) study first suggested that the drug may increase the risk of myocardial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr